# Eli Lilly and Company (LLY) — Q2-2009 Earnings Results

**Report date:** 2009-07-22 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2009

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 1.9%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.06 | N/A | +3.82% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and meeting patient needs.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, indicating stronger profitability than expected. However, the stock fell by 1.9%, which may reflect investor concerns about future growth or overall market conditions. The lack of revenue data and guidance could also contribute to uncertainty among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2009_